Dermatology

Gwillim EC, Azzawi S, Aigen AR. Underserved Populations and Health Equity in Dermatology: Digital Medicine and the Role of Artificial Intelligence. Clin Dermatol. 2024 Jun[...]

By sjmartinez • June 30, 2024

Lio PA, Armstrong A, Gutermuth J, Nosbaum A, Sofen H, Gil EG, Casillas M, Chen S, Sun L, Pierce E, Elmaraghy H, Dawson Z, Torres[...]

By sjmartinez • June 27, 2024

Anderson MS, Bennett RG. Repair of Large Lateral Forehead and Temporal Wound. Dermatol Surg. 2024 Jul 1;50(7):667-668. doi: 10.1097/DSS.0000000000004045. Epub 2023 Nov 30. PMID: 38048282.

By sjmartinez • June 27, 2024

Daly AE, Yeh G, Soltero S, Smale ST. Selective regulation of a defined subset of inflammatory and immunoregulatory genes by an NF-κB p50-IκBζ pathway. Genes[...]

By sjmartinez • June 26, 2024

Cheng JC, Swarup N, Morselli M, Huang WL, Aziz M, Caggiano C, Kordi M, Patel AA, Chia D, Kim Y, Li F, Wei F, Zaitlen[...]

By sjmartinez • June 24, 2024

Masson R, Seivright J, Grogan T, Atluri S, Hamzavi I, Hogeling M, Shi VY, Hsiao JL. Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis.[...]

By sjmartinez • June 23, 2024

Armstrong AW, Park SH, Patel V, Nicolas P, Wang WJ, Colombo MJ, Chirikov V. Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to[...]

By sjmartinez • June 23, 2024

Gebauer K, Spelman L, Yamauchi PS, Bagel J, Nishandar T, Crane M, Kopeloff I, Kothekar M, Yao SL, Sofen HL. Efficacy and safety of tildrakizumab[...]

By sjmartinez • June 22, 2024

Armstrong AW, Alexis AF, Blauvelt A, Silverberg JI, Feeney C, Levenberg M, Chan G, Zhang F, Fostvedt L. Predicting Abrocitinib Efficacy at Week 12 Based[...]

By sjmartinez • June 20, 2024

Greiling T, Young M, Seal MS, Higham RC, Armstrong A. Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey[...]

By sjmartinez • June 15, 2024